Moffitt Physicians Lead International Study to Identify Melanoma Patients with High-Risk Disease - Newswise

In a new study published in the Journal of Clinical Oncology, Moffitt Cancer Center physicians, along with a team of international researchers from eight other

Newswise — TAMPA, Fla. – The use of additional adjuvant therapy beyond initial treatment has greatly improved outcomes and reduced the risk of disease recurrence for high-risk patients with melanoma.… [+5472 chars]

full article...